Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ota

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bulletin of the American College of Surgeons|March 21, 2008
A phase II trial for minimally invasive esophagectomyDavid Ota, Heidi Nelson
Annals of Surgical Oncology|December 8, 2006
The surgeon and adjuvant therapy for stage II colon cancerDavid Ota, Heidi Nelson
Bulletin of the American College of Surgeons|April 1, 2011
Promoting patient safetyHeidi Nelson, David Ota
Surgery|June 3, 2009
The American College of Surgeons Oncology GroupY Nancy You, David Ota, Heidi Nelson
Surgery|November 4, 2004
Feasibility of breast duct lavage performed by a physician extenderPhilip N Redlich, Anna C Purdy, Vinod B Shidham, et al.
American Journal of Clinical Pathology|June 19, 2012
Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositoriesSandra A McDonald, Elaine R Mardis, David Ota, et al.
The New England Journal of Medicine|May 14, 2004
A comparison of laparoscopically assisted and open colectomy for colon cancer, Heidi Nelson, Daniel J Sargent, et al.
Cancer|December 8, 2005
Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population CommitteeLisa A Newman, Cheryl T Lee, Lina Patel Parekh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Nature|June 23, 2012
Whole-genome analysis informs breast cancer response to aromatase inhibitionMatthew J Ellis, Li Ding, Dong Shen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bulletin of the American College of Surgeons|March 21, 2008
A phase II trial for minimally invasive esophagectomyDavid Ota, Heidi Nelson
Annals of Surgical Oncology|December 8, 2006
The surgeon and adjuvant therapy for stage II colon cancerDavid Ota, Heidi Nelson
Bulletin of the American College of Surgeons|April 1, 2011
Promoting patient safetyHeidi Nelson, David Ota
Surgery|June 3, 2009
The American College of Surgeons Oncology GroupY Nancy You, David Ota, Heidi Nelson
Surgery|November 4, 2004
Feasibility of breast duct lavage performed by a physician extenderPhilip N Redlich, Anna C Purdy, Vinod B Shidham, et al.
American Journal of Clinical Pathology|June 19, 2012
Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositoriesSandra A McDonald, Elaine R Mardis, David Ota, et al.
The New England Journal of Medicine|May 14, 2004
A comparison of laparoscopically assisted and open colectomy for colon cancer, Heidi Nelson, Daniel J Sargent, et al.
Cancer|December 8, 2005
Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population CommitteeLisa A Newman, Cheryl T Lee, Lina Patel Parekh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Nature|June 23, 2012
Whole-genome analysis informs breast cancer response to aromatase inhibitionMatthew J Ellis, Li Ding, Dong Shen, et al.
Pageof 1